Cognex Corporation (FRA:CGZ)
47.33
-0.72 (-1.50%)
Last updated: Feb 20, 2026, 3:18 PM CET
Cognex Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 994.36 | 914.52 | 837.55 | 1,006 | 1,037 |
Revenue Growth (YoY) | 8.73% | 9.19% | -16.75% | -2.99% | 27.88% |
Cost of Revenue | 328.97 | 288.72 | 236.31 | 284.19 | 277.27 |
Gross Profit | 665.39 | 625.79 | 601.24 | 721.91 | 759.83 |
Selling, General & Admin | 363.86 | 370.91 | 339.14 | 312.11 | 309.35 |
Research & Development | 138.97 | 139.82 | 139.4 | 141.13 | 135.37 |
Operating Expenses | 502.83 | 510.73 | 478.54 | 453.24 | 444.73 |
Operating Income | 162.57 | 115.07 | 122.7 | 268.67 | 315.1 |
Interest & Investment Income | 16.95 | 13.97 | 14.09 | 6.72 | 6.66 |
Currency Exchange Gain (Loss) | -4.08 | 1.53 | -10.04 | -1.84 | -2.27 |
Other Non Operating Income (Expenses) | 2.32 | 0.92 | 0.59 | -0.41 | -0.59 |
EBT Excluding Unusual Items | 177.75 | 131.49 | 127.35 | 273.13 | 318.9 |
Merger & Restructuring Charges | - | - | - | -1.66 | - |
Gain (Loss) on Sale of Assets | 5.05 | - | - | - | - |
Other Unusual Items | - | - | - | -20.78 | - |
Pretax Income | 182.8 | 131.49 | 135.35 | 250.7 | 318.9 |
Income Tax Expense | 68.36 | 25.32 | 22.11 | 35.17 | 39.02 |
Earnings From Continuing Operations | 114.44 | 106.17 | 113.23 | 215.53 | 279.88 |
Net Income | 114.44 | 106.17 | 113.23 | 215.53 | 279.88 |
Net Income to Common | 114.44 | 106.17 | 113.23 | 215.53 | 279.88 |
Net Income Growth | 7.79% | -6.24% | -47.46% | -22.99% | 58.86% |
Shares Outstanding (Basic) | 168 | 171 | 172 | 173 | 176 |
Shares Outstanding (Diluted) | 169 | 173 | 173 | 175 | 180 |
Shares Change (YoY) | -1.88% | -0.45% | -0.84% | -2.80% | 1.88% |
EPS (Basic) | 0.68 | 0.62 | 0.66 | 1.24 | 1.59 |
EPS (Diluted) | 0.68 | 0.62 | 0.65 | 1.23 | 1.56 |
EPS Growth | 9.80% | -4.72% | -47.15% | -21.15% | 56.00% |
Free Cash Flow | 236.77 | 134.04 | 89.84 | 223.74 | 298.61 |
Free Cash Flow Per Share | 1.40 | 0.78 | 0.52 | 1.28 | 1.66 |
Dividend Per Share | 0.325 | 0.305 | 0.285 | 0.265 | 0.245 |
Dividend Growth | 6.56% | 7.02% | 7.55% | 8.16% | 8.89% |
Gross Margin | 66.92% | 68.43% | 71.79% | 71.75% | 73.27% |
Operating Margin | 16.35% | 12.58% | 14.65% | 26.70% | 30.38% |
Profit Margin | 11.51% | 11.61% | 13.52% | 21.42% | 26.99% |
Free Cash Flow Margin | 23.81% | 14.66% | 10.73% | 22.24% | 28.79% |
EBITDA | 193.36 | 147.75 | 144.58 | 288.29 | 335.38 |
EBITDA Margin | 19.45% | 16.16% | 17.26% | 28.65% | 32.34% |
D&A For EBITDA | 30.79 | 32.69 | 21.88 | 19.62 | 20.28 |
EBIT | 162.57 | 115.07 | 122.7 | 268.67 | 315.1 |
EBIT Margin | 16.35% | 12.58% | 14.65% | 26.70% | 30.38% |
Effective Tax Rate | 37.40% | 19.25% | 16.34% | 14.03% | 12.23% |
Advertising Expenses | 1.43 | 1.29 | 1.19 | 1.26 | 1.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.